在2022年CMS退款削减之后,心房动移除利用趋势:全国性的分析
Pranav Puri1, Daniel Moe1, Ashraf Alzahrani1
1University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.
Journal of cardiovascular electrophysiology
|September 10, 2025
概括
尽管医疗保险在2022年减少了对心房动 (AF) 废除的补偿,但手术量继续上升. 电生理学家进行了更多的AF切除,包括超出肺静脉隔离 (PVI) 的复杂程序.
科学领域:
- 心脏病学 心脏病学
- 卫生政策 卫生政策
- 卫生经济学 卫生经济学
背景情况:
- 美国医疗保险和医疗补助服务中心 (CMS) 在2022年颁布了一项捆绑支付政策,大大降低了对心房动 (AF) 移除的赔偿金.
- 这一政策变化引起了人们对其对AF切除程序的使用和复杂性的影响的担忧.
研究的目的:
- 分析2022年CMS政策调整后AF消去量,退款率和程序复杂性的国家趋势.
- 评估降低退款对 AF 切除实践的影响.
主要方法:
- 根据地理和服务数据集 (2016-2023) 使用了医疗保险医生和其他从业人员.
- 识别了肺静脉隔离 (PVI) 和使用特定CPT代码的额外除程序.
- 调整了通货膨胀和员工结合点回归的补偿率,以分析政策变化前后的趋势.
主要成果:
- 从2016年到2023年,全国AF切除量每年增长11.7%,为每年11.7%.
- 政策后,通胀调整后的退款在2022年下降了27.7%,在2023年下降了20%.
- 尽管补偿削减,总AF切除量增加了24.3% (2021-2023),超过PVI的程序上升了42.4%.
结论:
- 电生理学家维持并增加了AF切除量,即使从医疗保险的2022政策大幅减少退款.
- 除了PVI之外,进行额外的废除的趋势也继续上升,这表明政策变化对程序趋势没有重大影响.
相关概念视频
Issues And Trends In Healthcare Delivery System
6.2K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.2K
Dysrhythmias VI: Management of Dysrhythmias
435
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
435


